Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD

@inproceedings{Moretti2015ErdosteineRI,
  title={Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD},
  author={Maurizio Moretti and Stefano Fagnani},
  booktitle={International journal of chronic obstructive pulmonary disease},
  year={2015}
}
PURPOSE Mucolytics can improve disease outcome in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The objectives of this study were to investigate the effects of erdosteine (ER), a mucolytic agent with antioxidant activity, on systemic inflammation, symptoms, recurrence of exacerbation, and time to first exacerbation postdischarge in hospitalized patients with AECOPD. PATIENTS AND METHODS Patients admitted to hospital with AECOPD were randomized to receive… CONTINUE READING
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD

  • RW Dal Negro, M Visconti, C Micheletto, S. Tognella
  • Pulm Pharmacol Ther
  • 2008
3 Excerpts

Similar Papers

Loading similar papers…